Global Contact Center Industry Meets COVID-19 Challenge with Remote Work, Automation, AI STAMFORD, Conn., Oct. 12, 2020 (GLOBE NEWSWIRE) -- The global effects of the COVID-19 pandemic have forced contact centers to quickly change the way they operate and sharpened interest in new...

Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C ROCKVILLE, MD--(Marketwire - March 9, 2009) - -- 900-mcg Albuferon (albinterferon alfa-2b) dosed every two weeks met the primary efficacy endpoint of sustained virologic response comparable...